Open AccessCardiovascular safety and lower severe hypoglycaemia of insulin degludec versus insulin glargine U100 in patients with type 2 diabetes aged 65 years or older: Results from DEVOTE (DEVOTE 7)
Author(s) -
R.E. Pratley,
S.S. Emerson,
E. Franek,
M.P. Gilbert,
S.P. Marso,
D.K. McGuire,
T.R. Pieber,
B. Zinman,
C.T. Hansen,
M.V. Hansen,
T. Mark,
A.C. Moses,
J.B. Buse,
DEVOTE Study Group
Publication year - 2019
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/6txp-rv36
Subject(s) - insulin degludec , insulin glargine , medicine , insulin , endocrinology , diabetes mellitus , pediatrics , hypoglycemia